Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase

Takahiro Nobukuni(Cancer Genomics Centre), Manel Joaquin(Novartis (China)), Marta Roccio(Cancer Genomics Centre), Stephen G. Dann(Cancer Genomics Centre), So Young Kim(Cancer Genomics Centre), Pawan Gulati(Cancer Genomics Centre), Maya Byfield(Cancer Genomics Centre), Jonathan Backer(Cancer Genomics Centre), François Natt(Cancer Genomics Centre), Johannes L. Bos(Cancer Genomics Centre), Fried Zwartkruis(Cancer Genomics Centre), George Thomas(Novartis (China))
Proceedings of the National Academy of Sciences
September 21, 2005
Cited by 748Open Access
Full Text

Abstract

During the evolution of metazoans and the rise of systemic hormonal regulation, the insulin-controlled class 1 phosphatidylinositol 3OH-kinase (PI3K) pathway was merged with the primordial amino acid-driven mammalian target of rapamycin (mTOR) pathway to control the growth and development of the organism. Insulin regulates mTOR function through a recently described canonical signaling pathway, which is initiated by the activation of class 1 PI3K. However, how the amino acid input is integrated with that of the insulin signaling pathway is unclear. Here we used a number of molecular, biochemical, and pharmacological approaches to address this issue. Unexpectedly, we found that a major pathway by which amino acids control mTOR signaling is distinct from that of insulin and that, instead of signaling through components of the insulin/class 1 PI3K pathway, amino acids mediate mTOR activation by signaling through class 3 PI3K, hVps34.


Related Papers

No related papers found

Powered by citation graph analysis